210 related articles for article (PubMed ID: 20718504)
1. Role of the highly conserved middle region of prion protein (PrP) in PrP-lipid interaction.
Wang F; Yin S; Wang X; Zha L; Sy MS; Ma J
Biochemistry; 2010 Sep; 49(37):8169-76. PubMed ID: 20718504
[TBL] [Abstract][Full Text] [Related]
2. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
[TBL] [Abstract][Full Text] [Related]
3. Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity.
Timmes AG; Moore RA; Fischer ER; Priola SA
PLoS One; 2013; 8(7):e71081. PubMed ID: 23936256
[TBL] [Abstract][Full Text] [Related]
4. Heparin binding by murine recombinant prion protein leads to transient aggregation and formation of RNA-resistant species.
Vieira TC; Reynaldo DP; Gomes MP; Almeida MS; Cordeiro Y; Silva JL
J Am Chem Soc; 2011 Jan; 133(2):334-44. PubMed ID: 21142149
[TBL] [Abstract][Full Text] [Related]
5. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
[TBL] [Abstract][Full Text] [Related]
6. Lipid interaction converts prion protein to a PrPSc-like proteinase K-resistant conformation under physiological conditions.
Wang F; Yang F; Hu Y; Wang X; Wang X; Jin C; Ma J
Biochemistry; 2007 Jun; 46(23):7045-53. PubMed ID: 17503780
[TBL] [Abstract][Full Text] [Related]
7. Methionine oxidation interferes with conversion of the prion protein into the fibrillar proteinase K-resistant conformation.
Breydo L; Bocharova OV; Makarava N; Salnikov VV; Anderson M; Baskakov IV
Biochemistry; 2005 Nov; 44(47):15534-43. PubMed ID: 16300402
[TBL] [Abstract][Full Text] [Related]
8. The N-Terminal Polybasic Region of Prion Protein Is Crucial in Prion Pathogenesis Independently of the Octapeptide Repeat Region.
Das NR; Miyata H; Hara H; Chida J; Uchiyama K; Masujin K; Watanabe H; Kondoh G; Sakaguchi S
Mol Neurobiol; 2020 Feb; 57(2):1203-1216. PubMed ID: 31707632
[TBL] [Abstract][Full Text] [Related]
9. Conformational properties of prion strains can be transmitted to recombinant prion protein fibrils in real-time quaking-induced conversion.
Sano K; Atarashi R; Ishibashi D; Nakagaki T; Satoh K; Nishida N
J Virol; 2014 Oct; 88(20):11791-801. PubMed ID: 25078700
[TBL] [Abstract][Full Text] [Related]
10. Role of the central lysine cluster and scrapie templating in the transmissibility of synthetic prion protein aggregates.
Groveman BR; Raymond GJ; Campbell KJ; Race B; Raymond LD; Hughson AG; Orrú CD; Kraus A; Phillips K; Caughey B
PLoS Pathog; 2017 Sep; 13(9):e1006623. PubMed ID: 28910420
[TBL] [Abstract][Full Text] [Related]
11. Liquid-liquid phase separation of full-length prion protein initiates conformational conversion in vitro.
Tange H; Ishibashi D; Nakagaki T; Taguchi Y; Kamatari YO; Ozawa H; Nishida N
J Biol Chem; 2021; 296():100367. PubMed ID: 33545172
[TBL] [Abstract][Full Text] [Related]
12. De novo generation of infectious prions with bacterially expressed recombinant prion protein.
Zhang Z; Zhang Y; Wang F; Wang X; Xu Y; Yang H; Yu G; Yuan C; Ma J
FASEB J; 2013 Dec; 27(12):4768-75. PubMed ID: 23970796
[TBL] [Abstract][Full Text] [Related]
13. Binding of recombinant but not endogenous prion protein to DNA causes DNA internalization and expression in mammalian cells.
Yin S; Fan X; Yu S; Li C; Sy MS
J Biol Chem; 2008 Sep; 283(37):25446-25454. PubMed ID: 18622017
[TBL] [Abstract][Full Text] [Related]
14. Preserving prion strain identity upon replication of prions in vitro using recombinant prion protein.
Makarava N; Savtchenko R; Lasch P; Beekes M; Baskakov IV
Acta Neuropathol Commun; 2018 Sep; 6(1):92. PubMed ID: 30208966
[TBL] [Abstract][Full Text] [Related]
15. A new mechanism for transmissible prion diseases.
Makarava N; Kovacs GG; Savtchenko R; Alexeeva I; Ostapchenko VG; Budka H; Rohwer RG; Baskakov IV
J Neurosci; 2012 May; 32(21):7345-55. PubMed ID: 22623680
[TBL] [Abstract][Full Text] [Related]
16. Hydration and packing effects on prion folding and beta-sheet conversion. High pressure spectroscopy and pressure perturbation calorimetry studies.
Cordeiro Y; Kraineva J; Ravindra R; Lima LM; Gomes MP; Foguel D; Winter R; Silva JL
J Biol Chem; 2004 Jul; 279(31):32354-9. PubMed ID: 15173173
[TBL] [Abstract][Full Text] [Related]
17. A Promising Antiprion Trimethoxychalcone Binds to the Globular Domain of the Cellular Prion Protein and Changes Its Cellular Location.
Ferreira NC; Ascari LM; Hughson AG; Cavalheiro GR; Góes CF; Fernandes PN; Hollister JR; da Conceição RA; Silva DS; Souza AMT; Barbosa MLC; Lara FA; Martins RAP; Caughey B; Cordeiro Y
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133563
[TBL] [Abstract][Full Text] [Related]
18. The amino-terminal PrP domain is crucial to modulate prion misfolding and aggregation.
Cordeiro Y; Kraineva J; Gomes MP; Lopes MH; Martins VR; Lima LM; Foguel D; Winter R; Silva JL
Biophys J; 2005 Oct; 89(4):2667-76. PubMed ID: 16040743
[TBL] [Abstract][Full Text] [Related]
19. PK-sensitive PrP is infectious and shares basic structural features with PK-resistant PrP.
Sajnani G; Silva CJ; Ramos A; Pastrana MA; Onisko BC; Erickson ML; Antaki EM; Dynin I; Vázquez-Fernández E; Sigurdson CJ; Carter JM; Requena JR
PLoS Pathog; 2012; 8(3):e1002547. PubMed ID: 22396643
[TBL] [Abstract][Full Text] [Related]
20. A C-terminal membrane anchor affects the interactions of prion proteins with lipid membranes.
Chu NK; Shabbir W; Bove-Fenderson E; Araman C; Lemmens-Gruber R; Harris DA; Becker CF
J Biol Chem; 2014 Oct; 289(43):30144-60. PubMed ID: 25217642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
